To investigate levels of biomarkers of endothelial dysfunctions, subclinical atherosclerosis, and associated cellular senescence in blood vessels, aortic mRNA gene expression of eNOS, SMP-30, and P53 were estimated and presented in Table 2 and Figure 1. This evidence concerns the gene RGN and endothelial dysfunction.